Obinutuzumab & Rituximab Safety Risks

Поделиться
HTML-код
  • Опубликовано: 24 июл 2024
  • An overview of the safety risks of patients with follicular lymphoma at high risk for early progression taking either obinutuzumab or rituximab.
    For more resources and information regarding anticancer targeted therapies: targetedonc.com/

Комментарии •